Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem for Myocardial Perfusion in Isolated Coronary Artery Ectasia
NCT02024919Completed
- Sponsor
- Ankara University
- Start
- Jun 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of diltiazem in Coronary artery ectasia (CAE) (2 arms), sponsored by Ankara University. Primary endpoints: Myocardial Blush Grade at 3 minutes, Thrombolysis In Myocardial Infarction Flow Grade at 3 minutes and 1 more. Started Jun 2012; status: completed.
02
Drugs
diltiazem
03
Conditions
Coronary artery ectasia (CAE)
Beyond the preview
Go deeper on NCT02024919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024919.